3 results about "Octyl cyanoacrylate" patented technology

The present invention provides a cyanoacrylate composition that improves high-temperature strength performance while maintaining a desirable level of heat resistance. [Solution] A cyanoacrylate composition is provided, comprising (a) a cyanoacrylate component comprising a combination of (i) allyl cyanoacrylate and (ii) another cyanoacrylate selected from the group consisting of methyl cyanoacrylate, ethyl-2-cyanoacrylate, propyl cyanoacrylate, butyl cyanoacrylate, octyl cyanoacrylate and β-methoxyethyl cyanoacrylate, (b) fluorobenzonitrile, (c) hydrogenated aromatic anhydride, and (d) a reinforcing component.

The invention relates to the field of biomedical materials, in particular to cyanoacrylate medical blood vessel blocking glue and a preparation method thereof.The cyanoacrylate medical blood vessel blocking glue is prepared from, by mass, 30-35 parts of 2-octyl cyanoacrylate, 7-8 parts of lactide modified hydroxyethyl methylacrylate, 0.02-0.03 part of polymerization inhibitor propyl gallate, 0.02-0.03 part of initiator, 0.02-0.03 part of initiator, 0.02-0.03 part of initiator, 0.02-0.03 part of initiator and the balance water. By innovatively adopting various functional components and carrying out synergistic compatibility and precise preparation, compared with the prior art, the comprehensive performance of the product is remarkably improved, and the plugging agent has the advantages of rapid and reliable plugging effect, good plugging effect, good plugging effect, good plugging effect, good plugging effect, good plugging effect, good plugging effect, good plugging effect, good plugging effect and the like. Meanwhile, good biocompatibility, intraoperative developing capacity and a potential drug sustained release function are achieved, operation is easy and convenient, performance is stable, a safer and more efficient choice is provided for clinical vascular interventional therapy, and wide application prospects are achieved in the fields of cardiovascular and neurological intervention, peripheral vascular embolism and the like.

This invention relates to a photocurable composition comprising: cyanoacrylate A selected from the group consisting of n-hexyl cyanoacrylate, n-heptyl cyanoacrylate, n-octyl cyanoacrylate, and mixtures thereof; a free radical photoinitiator; a metallocene compound; compound B selected from the group consisting of boron trifluoride, boron trifluoride diethyl ether, boron trifluoride dihydrate, boron trifluoride ethanol, boron trifluoride methanol, boron trifluoride acetic acid, boron trifluoride butyl ether, boron trifluoride butanol, boron trifluoride propanol, boron trifluoride dimethyl sulfide, boron trifluoride acetonitrile, boron trifluoride tetrahydrofuran, and boron trifluoride isopropanol; and optionally a free radical polymerization inhibitor, provided that when the photocurable composition contains a free radical polymerization inhibitor, its weight content is 0.04 wt.% or less; wherein the molar content of compound B is greater than or equal to 0.141 mmol per 1 kg of composition; and wherein the molar ratio of metallocene compound / compound B ranges from 2 to 8.